Indeed, a recent case report suggests administration of metformin in a patient with SLC13A5-associated early infantile epileptic encephalopathy-25 (EIEE-25) may increase the psychiatric episodes, while discontinuation of metformin revealed improved clinical manifestation [54]. This evidence concerns the gene SLC13A5 and genetic developmental and epileptic encephalopathy.